US00791X1000 - AEON (XNYS)
AEON Biopharma, Inc. Class A Common Stock Action
0,60 USD
Cours actuels de AEON Biopharma, Inc. Class A Common Stock
Bourse | Ticker | Devise | Dernier échange | Cours | Variation journalière | Variation journalière % |
---|---|---|---|---|---|---|
NYSE |
AEON
|
USD
|
24.12.2024 12:30
|
0,60 USD
| 0,60 USD | -0,02 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
-0,08 % | -4,66 % | 11,66 % | -14,37 % | -45,01 % | -89,58 % | -93,48 % |
Company Profile for AEON Biopharma, Inc. Class A Common Stock Share
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.
Company Data for AEON Biopharma, Inc. Class A Common Stock Share
Name AEON Biopharma, Inc. Class A Common Stock
Company AEON Biopharma, Inc.
Symbol AEON
Website http://www.aeonbiopharma.com
Primary Exchange
NYSE
ISIN US00791X1000
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Marc Forth
Market Capitalization 33 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 4040 Macarthur Boulevard, 92614 Newport Beach
IPO Date 2023-07-24
Ticker Symbols
Name | Symbol |
---|---|
NYSE | AEON |
More Shares
Investors who AEON Biopharma, Inc. Class A Common Stock hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.